| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |